Estimating the parameter distributions of defibrillation shock efficacy curves in a large population

Annals of Biomedical Engineering

Volumn 38, Issue 4, 2010, Pages 1314-1325

  Smits, Karel ^a   Virag, Nathalie ^a,b  

^a MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^b Medtronic Europe   (Switzerland)

Author keywords

Defibrillation threshold; Dose response curve; Implantable cardioverter defibrillator; Monte Carlo method

Indexed keywords

BINARY SEARCH; CLINICAL OBSERVATION; CLINICAL PRACTICES; CLINICAL STUDY; DOSE RESPONSE; DOSE RESPONSE RELATIONSHIPS; DOSE-RESPONSE CURVE; EFFICACY TESTING; ESTIMATED PARAMETER; FREQUENCY DISTRIBUTIONS; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; LARGE POPULATION; OPTIMAL PARAMETER; PARAMETER DISTRIBUTIONS; REJECTION RATES; SAFETY MARGIN; SHOCK ENERGY; TESTING PROTOCOLS; THRESHOLD DOSE; TWO PARAMETER;

DEFIBRILLATORS; MONTE CARLO METHODS; PARAMETER ESTIMATION; SAFETY TESTING;

SHOCK TESTING;

ARTICLE; BIOLOGICAL MODEL; CARDIOVERSION; COMPUTER ASSISTED THERAPY; COMPUTER SIMULATION; HEART ARRHYTHMIA; HEART RATE; HUMAN; INCIDENCE; METHODOLOGY; PATHOPHYSIOLOGY; POPULATION DYNAMICS; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; INCIDENCE; MODELS, CARDIOVASCULAR; MODELS, STATISTICAL; POPULATION DYNAMICS; STATISTICAL DISTRIBUTIONS; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 77952010764     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-009-9890-z     Document Type: Article

References (27)

1. SS Barold B Herweg AB Curtis 2005 The defibrillation safety margin of patients receiving ICDs: a matter of definition Pacing Clin. Electrophysiol. 28 881 882 10.1111/j.1540-8159.2005.00191.x 16176523 (Pubitemid 43960859)
2. PD Chapman JW Vetter JJ Souza PJ Troup JN Wetherbee RG Hoffmann 1988 Comparative efficacy of monophasic and biphasic truncated exponential shocks for nonthoracotomy internal defibrillation in dogs J. Am. Coll. Cardiol. 12 739 745 1:STN:280:DyaL1c3pvFeqsw%3D%3D 3403834
3. JM Davy ES Fain P Dorian RA Winkle 1987 The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept Am. Heart J. 113 77 84 10.1016/0002-8703(87)90012-3 1:STN:280:DyaL2s%2Fps12ruw%3D%3D 3799444 (Pubitemid 17225050)
4. PJ DeGroot TR Church R Mehra MS Martinson DE Schaber 1997 Derivation of a defibrillator implant criterion based on probability of successful defibrillation Pacing Clin. Electrophysiol. 20 1924 1935 10.1111/j.1540-8159. 1997.tb03598.x 1:STN:280:DyaK2svhvVGluw%3D%3D 9272530 (Pubitemid 27349492)
5. DS Echt JT Barbey JN Black 1988 Influence of ventricular fibrillation duration on defibrillation energy in dogs using bidirectional pulse discharges Pacing Clin. Electrophysiol. 11 1315 1323 10.1111/j.1540-8159.1988.tb03994.x 1:STN:280:DyaL1M%2FktFKksg%3D%3D 2460837 (Pubitemid 19005749)
6. PA Friedman DA Foley TF Christian MS Stanton 1988 Stability of the defibrillation probability curve with the development of ventricular dysfunction in the canine rapid paced model Pacing Clin. Electrophysiol. 21 339 351 10.1111/j.1540-8159.1998.tb00058.x
7. MR Gold S Higgins R Klein, et al. 2002 Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS) Circulation 105 2043 2048 10.1161/01.CIR. 0000015508.59749.F5 11980683 (Pubitemid 34465266)
8. R Gradaus M Block K Seidl, et al. 2001 Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II J. Cardiovasc. Electrophysiol. 12 921 927 10.1046/j.1540-8167.2001.00921.x 1:STN:280:DC%2BD3MvmvVGqtQ%3D%3D 11513444
9. OT Gurewitz PA Friedman M Glikson JM Trusty KV Ballman AG Rosales DL Hayes SC Hammill CD Swerdlow 2003 Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictor J. Cardiovasc. Electrophysiol. 14 728 732
10. KM Kavanagh AS Tang DL Rollins WM Smith RE Ideker 1989 Comparison of the internal defibrillation thresholds for monophasic and double and single capacitor biphasic waveforms J. Am. Coll. Cardiol. 14 1343 1349 10.1016/0735-1097(89)90439-7 1:STN:280:DyaK3c%2FjvVSgsQ%3D%3D 2808992 (Pubitemid 19268690)
11. SK Mainigi DJ Callans 2006 How to manage the patient with a high defibrillation threshold Heart Rhythm 3 492 495 10.1016/j.hrthm.2005.12.023 16567304
12. RA Malkin SF Idriss RG Walker RE Ideker 1995 Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves Circulation 92 1291 1299 1:STN:280:DyaK2Mzns1Oksg%3D%3D 7648678
13. FE Marchlinski B Flores JM Miller CD Gottlieb WC Hargrove III 1988 Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator Am. J. Cardiol. 62 393 398 10.1016/0002-9149(88)90965-4 1:STN:280:DyaL1czisVWjug%3D%3D 3414516
14. WC McDaniel JC Schuder 1987 The cardiac ventricular defibrillation threshold: inherent limitations in its application and interpretation Med. Instrum. 21 170 176 1:STN:280:DyaL2s3os1Gmug%3D%3D 3614040
15. Y Murakawa BE Gliner NV Thakor 1989 Success rate versus defibrillation energy: temporal profile and the most efficient defibrillation threshold Am. Heart J. 118 451 458 10.1016/0002-8703(89)90257-3 1:STN:280:DyaL1MzntFCmtw%3D%3D 2773769 (Pubitemid 19222037)
16. Y Murakawa T Yamashita K Ajiki K Sezaki M Omata 1996 Effects of a class III antiarrhythmic drug and biphasic shocks on the postdefibrillation refractory period of relatively refractory myocardium J. Cardiovasc. Electrophysiol. 7 603 611 10.1111/j.1540-8167.1996.tb00568.x 1:STN:280:DyaK28vgtFSgsg%3D%3D 8807406
17. d Newman A Barr M Greene, et al. 1997 A population-based method for the estimation of defibrillation energy requirements in humans. Assessment of time-dependent effects with a transvenous defibrillation system Circulation 96 267 273 1:STN:280:DyaK2sznvFKntw%3D%3D 9236444
18. LA Pires KM Johnson 2006 Intraoperative testing of the implantable cardioverter-defibrillator: How much is enough? J. Cardiovasc. Electrophysiol. 17 140 145 10.1111/j.1540-8167.2005.00294.x 16533250 (Pubitemid 43344864)
19. MF Rattes DL Jones AD Sharma GJ Klein 1987 Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate Pacing Clin. Electrophysiol. 10 70 77 10.1111/j.1540-8159.1987.tb05926.x 1:STN:280: DyaL2s7nsFSlsA%3D%3D 2436171 (Pubitemid 17010562)
20. AM Russo W Sauer EP Gerstenfeld, et al. 2005 Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter- defibrillator insertion? Heart Rhythm 2 456 461 10.1016/j.hrthm.2005.01.015 15840466 (Pubitemid 40521355)
21. SR Shorofsky RW Peters EJ Rashba MR Gold 2004 Comparison of step-down and binary search algorithms for determination of defibrillation thresholds in humans Pacing Clin. Electrophysiol. 27 218 220 10.1111/j.1540-8159.2004.00413.x 14764173 (Pubitemid 38251017)
22. HH Shukla GC Flaker V Jayam D Roberts 2003 High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications Pacing Clin. Electrophysiol. 26 44 48 10.1046/j.1460-9592.2003.00148.x 12685138
23. I Singer D Lang 1992 Defibrillation threshold: clinical utility and therapeutic implications Pacing Clin. Electrophysiol. 15 932 949 10.1111/j.1540-8159.1992.tb03083.x 1:STN:280:DyaK38zgt1Sltg%3D%3D 1376905
24. JJ Souza RA Malkin RE Ideker 1995 Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system Circulation 91 1247 1252 1:STN:280: DyaK2M7ltlymsw%3D%3D 7850965
25. S Toal L Harris J Asta A Hill D Cameron 2006 Routine defibrillation threshold testing at implant in patients receiving defibrillators for primary prevention: Is this necessary? Heart Rhythm 3 S157 10.1016/j.hrthm.2006.02.469
26. MS Wathen PJ DeGroot MO Sweeney, et al. 2004 Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2591 2596 10.1161/01.CIR.0000145610.64014.E4 15492306 (Pubitemid 39453007)
27. S Windecker RE Ideker VJ Plumb GN Kay GP Walcott AE Epstein 1999 The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans J. Am. Coll. Cardiol. 33 33 38 10.1016/S0735- 1097(98)00529-4 1:STN:280:DyaK1M7jtFOjtg%3D%3D 9935005 (Pubitemid 29064069)